421 related articles for article (PubMed ID: 28950731)
1. Unbiased Identification of T-Cell Receptors Targeting Immunodominant Peptide-MHC Complexes for T-Cell Receptor Immunotherapy.
Lorenz FKM; Ellinger C; Kieback E; Wilde S; Lietz M; Schendel DJ; Uckert W
Hum Gene Ther; 2017 Dec; 28(12):1158-1168. PubMed ID: 28950731
[TBL] [Abstract][Full Text] [Related]
2. Generation of Epstein-Barr Virus Antigen-Specific T Cell Receptors Recognizing Immunodominant Epitopes of LMP1, LMP2A, and EBNA3C for Immunotherapy.
Dudaniec K; Westendorf K; Nössner E; Uckert W
Hum Gene Ther; 2021 Sep; 32(17-18):919-935. PubMed ID: 33798008
[TBL] [Abstract][Full Text] [Related]
3. Isolation of T cell receptors targeting recurrent neoantigens in hematological malignancies.
Tubb VM; Schrikkema DS; Croft NP; Purcell AW; Linnemann C; Freriks MR; Chen F; Long HM; Lee SP; Bendle GM
J Immunother Cancer; 2018 Jul; 6(1):70. PubMed ID: 30001747
[TBL] [Abstract][Full Text] [Related]
4. Isolation and Characterization of an HLA-DRB1*04-Restricted HPV16-E7 T Cell Receptor for Cancer Immunotherapy.
Mercier-Letondal P; Marton C; Deschamps M; Ferrand C; Vauchy C; Chenut C; Baguet A; Adotévi O; Borg C; Galaine J; Godet Y
Hum Gene Ther; 2018 Oct; 29(10):1202-1212. PubMed ID: 30136612
[TBL] [Abstract][Full Text] [Related]
5. Peptide-MHC Binding Reveals Conserved Allosteric Sites in MHC Class I- and Class II-Restricted T Cell Receptors (TCRs).
He Y; Agnihotri P; Rangarajan S; Chen Y; Kerzic MC; Ma B; Nussinov R; Mariuzza RA; Orban J
J Mol Biol; 2020 Dec; 432(24):166697. PubMed ID: 33157083
[TBL] [Abstract][Full Text] [Related]
6. Critical biological parameters modulate affinity as a determinant of function in T-cell receptor gene-modified T-cells.
Spear TT; Wang Y; Foley KC; Murray DC; Scurti GM; Simms PE; Garrett-Mayer E; Hellman LM; Baker BM; Nishimura MI
Cancer Immunol Immunother; 2017 Nov; 66(11):1411-1424. PubMed ID: 28634816
[TBL] [Abstract][Full Text] [Related]
7. Identification of a Novel Immunodominant HLA-B*07: 02-restricted Adenoviral Peptide Epitope and Its Potential in Adoptive Transfer Immunotherapy.
Günther PS; Peper JK; Faist B; Kayser S; Hartl L; Feuchtinger T; Jahn G; Neuenhahn M; Busch DH; Stevanović S; Dennehy KM
J Immunother; 2015 Sep; 38(7):267-75. PubMed ID: 26261890
[TBL] [Abstract][Full Text] [Related]
8. High-throughput peptide-MHC complex generation and kinetic screenings of TCRs with peptide-receptive HLA-A*02:01 molecules.
Moritz A; Anjanappa R; Wagner C; Bunk S; Hofmann M; Pszolla G; Saikia A; Garcia-Alai M; Meijers R; Rammensee HG; Springer S; Maurer D
Sci Immunol; 2019 Jul; 4(37):. PubMed ID: 31324691
[TBL] [Abstract][Full Text] [Related]
9. Key Features Relevant to Select Antigens and TCR From the MHC-Mismatched Repertoire to Treat Cancer.
Audehm S; Glaser M; Pecoraro M; Bräunlein E; Mall S; Klar R; Effenberger M; Albers J; Bianchi HO; Peper J; Yusufi N; Busch DH; Stevanović S; Mann M; Antes I; Krackhardt AM
Front Immunol; 2019; 10():1485. PubMed ID: 31316521
[TBL] [Abstract][Full Text] [Related]
10. Generation of TGFβR2(-1) neoantigen-specific HLA-DR4-restricted T cell receptors for cancer therapy.
Plewa N; Poncette L; Blankenstein T
J Immunother Cancer; 2023 Feb; 11(2):. PubMed ID: 36822673
[TBL] [Abstract][Full Text] [Related]
11. Dendritic cells pulsed with RNA encoding allogeneic MHC and antigen induce T cells with superior antitumor activity and higher TCR functional avidity.
Wilde S; Sommermeyer D; Frankenberger B; Schiemann M; Milosevic S; Spranger S; Pohla H; Uckert W; Busch DH; Schendel DJ
Blood; 2009 Sep; 114(10):2131-9. PubMed ID: 19587379
[TBL] [Abstract][Full Text] [Related]
12. Engineering improved T cell receptors using an alanine-scan guided T cell display selection system.
Malecek K; Zhong S; McGary K; Yu C; Huang K; Johnson LA; Rosenberg SA; Krogsgaard M
J Immunol Methods; 2013 Jun; 392(1-2):1-11. PubMed ID: 23500145
[TBL] [Abstract][Full Text] [Related]
13. Treatment of Patients With Metastatic Cancer Using a Major Histocompatibility Complex Class II-Restricted T-Cell Receptor Targeting the Cancer Germline Antigen MAGE-A3.
Lu YC; Parker LL; Lu T; Zheng Z; Toomey MA; White DE; Yao X; Li YF; Robbins PF; Feldman SA; van der Bruggen P; Klebanoff CA; Goff SL; Sherry RM; Kammula US; Yang JC; Rosenberg SA
J Clin Oncol; 2017 Oct; 35(29):3322-3329. PubMed ID: 28809608
[TBL] [Abstract][Full Text] [Related]
14. Recombinant antibodies with MHC-restricted, peptide-specific, T-cell receptor-like specificity: new tools to study antigen presentation and TCR-peptide-MHC interactions.
Cohen CJ; Denkberg G; Lev A; Epel M; Reiter Y
J Mol Recognit; 2003; 16(5):324-32. PubMed ID: 14523945
[TBL] [Abstract][Full Text] [Related]
15. Generation of CD20-specific TCRs for TCR gene therapy of CD20low B-cell malignancies insusceptible to CD20-targeting antibodies.
Jahn L; van der Steen DM; Hagedoorn RS; Hombrink P; Kester MG; Schoonakker MP; de Ridder D; van Veelen PA; Falkenburg JH; Heemskerk MH
Oncotarget; 2016 Nov; 7(47):77021-77037. PubMed ID: 27776339
[TBL] [Abstract][Full Text] [Related]
16. Optimization of T-cell Reactivity by Exploiting TCR Chain Centricity for the Purpose of Safe and Effective Antitumor TCR Gene Therapy.
Ochi T; Nakatsugawa M; Chamoto K; Tanaka S; Yamashita Y; Guo T; Fujiwara H; Yasukawa M; Butler MO; Hirano N
Cancer Immunol Res; 2015 Sep; 3(9):1070-81. PubMed ID: 25943533
[TBL] [Abstract][Full Text] [Related]
17. TCR Fingerprinting and Off-Target Peptide Identification.
Karapetyan AR; Chaipan C; Winkelbach K; Wimberger S; Jeong JS; Joshi B; Stein RB; Underwood D; Castle JC; van Dijk M; Seibert V
Front Immunol; 2019; 10():2501. PubMed ID: 31695703
[TBL] [Abstract][Full Text] [Related]
18. Impact of CD8-MHC class I interaction in detection and sorting efficiencies of antigen-specific T cells using MHC class I/peptide multimers: contribution of pMHC valency.
Neveu B; Echasserieau K; Hill T; Kuus-Reichel K; Houssaint E; Bonneville M; Saulquin X
Int Immunol; 2006 Jul; 18(7):1139-45. PubMed ID: 16751231
[TBL] [Abstract][Full Text] [Related]
19. Deciphering CD4
Kisielow J; Obermair FJ; Kopf M
Nat Immunol; 2019 May; 20(5):652-662. PubMed ID: 30858620
[TBL] [Abstract][Full Text] [Related]
20. Structure-Based, Rational Design of T Cell Receptors.
Zoete V; Irving M; Ferber M; Cuendet MA; Michielin O
Front Immunol; 2013 Sep; 4():268. PubMed ID: 24062738
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
